Using novel point-of-care diagnostic tests and mathematical modelling to achieve hepatitis B elimination: The Rapid B Study

使用新型即时诊断测试和数学模型来消除乙型肝炎：快速乙型肝炎研究

• 批准号: nhmrc : 2002268
• 金额: $ 38.19万
• 依托单位国家: 澳大利亚
• 项目类别: Ideas Grants
• 财政年份: 2021
• 资助国家: 澳大利亚
• 起止时间: 2021-01-01 至 2022-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/using-novel-point-b-study/1779882
• 关键词: Using; novel; point; care; diagnostic; Using; novel; point; care; diagnostic

Liver cancer is increasing rapidly in Australia and globally and depite hepatitis B virus infection being the leading cause, treatment rates are low. We have developed innovative point-of-care blood tests that use a single droplet of blood to measure liver damage, that will help overcome barriers to treatment uptake worldwide. The Rapid B Study will use mathematical modelling to investigate the most cost-effective way to combine these novel tests with treatment to reduce liver cancer deaths.

在澳大利亚和全球范围内，肝癌正在迅速增加，而Depite丙型肝炎病毒感染是主要原因，治疗率很低。我们已经开发了创新的护理血液测试，这些血液测试使用单滴血液来测量肝脏损害，这将有助于克服全球治疗摄取的障碍。快速B研究将使用数学建模来研究将这些新型测试与治疗相结合以减少肝癌死亡的最具成本效益的方式。